Recombinant Human ZEB2 Protein, N-GST & C-His from ProteoGenix; catalogue ARO-P12594; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human ZEB2 Protein, also known as Zinc Finger E-Box Binding Homeobox 2, is a transcription factor that plays a crucial role in various biological processes, including embryonic development, cell differentiation, and tumor progression. This protein is encoded by the ZEB2 gene and is a member of the ZEB family of transcription factors.
The recombinant form of ZEB2 protein is a 200 kDa protein consisting of 1212 amino acids. It contains several structural domains, including two zinc finger domains, a homeobox domain, and a C-terminal domain. The zinc finger domains are responsible for DNA binding, while the homeobox domain is involved in protein-protein interactions. The C-terminal domain is responsible for transcriptional activation and repression.
Recombinant Human ZEB2 Protein is a transcription factor that regulates gene expression by binding to specific DNA sequences. It is primarily involved in the process of epithelial to mesenchymal transition (EMT), which is essential for embryonic development and wound healing. EMT is also implicated in tumor progression and metastasis, making ZEB2 an important target for cancer research.
ZEB2 can act as both a transcriptional activator and a repressor, depending on the target gene and cellular context. It regulates the expression of genes involved in cell adhesion, migration, and invasion, which are crucial for EMT and tumor progression. ZEB2 also plays a role in maintaining the balance between stem cell self-renewal and differentiation.
Recombinant Human ZEB2 Protein has various applications in both research and clinical settings. Here are some of the key applications of this protein:
As mentioned earlier, ZEB2 is a critical regulator of EMT, which is involved in cancer progression and metastasis. Therefore, recombinant ZEB2 protein is widely used in cancer research to study the mechanisms of EMT and identify potential therapeutic targets. It is also used to evaluate the efficacy of anti-cancer drugs that target ZEB2 or its downstream signaling pathways.
ZEB2 is essential for embryonic development, particularly in the formation of various tissues and organs. Recombinant Human ZEB2 Protein is used to study the role of this transcription factor in different developmental processes, such as neural crest formation and limb development. It is also used to generate animal models with altered ZEB2 expression, which helps in understanding the consequences of ZEB2 dysfunction.
Recombinant Human ZEB2 Protein is also used in tissue engineering to promote the differentiation of stem cells into specific cell types. ZEB2 is known to play a role in the differentiation of mesenchymal stem cells into osteoblasts and chondrocytes. Therefore, recombinant ZEB2 protein is used to induce the differentiation of stem cells into these cell types, which can be used for regenerative medicine and tissue repair.
ZEB2 has been identified as a potential biomarker for various diseases, including cancer and developmental disorders. Recombinant Human ZEB2 Protein is used in diagnostic assays to detect the levels of this protein in patient samples. Abnormal levels of ZEB2 can indicate the presence of certain diseases or help in disease prognosis.
Given the critical role of ZEB2 in cancer progression, it is being explored as a potential therapeutic target. Recombinant Human ZEB2 Protein can be used to develop drugs that specifically target this transcription factor and inhibit its activity. This can potentially lead to the development of novel treatments for cancer and other diseases associated with ZEB2 dysfunction.
In summary
ProteoGenix catalogue number ARO-P12594. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 35.15 kDa; Fragment: Ser647-Ser705; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
